166 related articles for article (PubMed ID: 31054132)
1. Injectable Antihyperglycemics: A Systematic Review and Critical Analysis of the Literature on Adherence, Persistence, and Health Outcomes.
Hamersky CM; Fridman M; Gamble CL; Iyer NN
Diabetes Ther; 2019 Jun; 10(3):865-890. PubMed ID: 31054132
[TBL] [Abstract][Full Text] [Related]
2. Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus.
Sicras-Mainar A; Navarro-Artieda R; Morano R; Ruíz L
Endocrinol Nutr; 2016 Dec; 63(10):527-535. PubMed ID: 27744013
[TBL] [Abstract][Full Text] [Related]
3. Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review.
Evans M; Engberg S; Faurby M; Fernandes JDDR; Hudson P; Polonsky W
Diabetes Obes Metab; 2022 Mar; 24(3):377-390. PubMed ID: 34779107
[TBL] [Abstract][Full Text] [Related]
4. Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US.
Lin J; Lingohr-Smith M; Fan T
Clinicoecon Outcomes Res; 2017; 9():19-29. PubMed ID: 28053550
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Insulin Adherence Measures in Patients with Diabetes.
Stolpe S; Kroes MA; Webb N; Wisniewski T
J Manag Care Spec Pharm; 2016 Nov; 22(11):1224-1246. PubMed ID: 27783551
[TBL] [Abstract][Full Text] [Related]
6. Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement.
Giorgino F; Penfornis A; Pechtner V; Gentilella R; Corcos A
Patient Prefer Adherence; 2018; 12():707-719. PubMed ID: 29765207
[TBL] [Abstract][Full Text] [Related]
7. Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review.
Kennedy-Martin T; Boye KS; Peng X
Patient Prefer Adherence; 2017; 11():1103-1117. PubMed ID: 28721024
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting.
Melzer-Cohen C; Chodick G; Naftelberg S; Shehadeh N; Karasik A
Diabetes Ther; 2020 Jan; 11(1):185-196. PubMed ID: 31808132
[TBL] [Abstract][Full Text] [Related]
9. Impact of Weight Change in Adults with Type 2 Diabetes Mellitus: A Literature Review and Critical Analysis.
Fridman M; Lucas ME; Paprocki Y; Dang-Tan T; Iyer NN
Clinicoecon Outcomes Res; 2020; 12():555-566. PubMed ID: 33061488
[TBL] [Abstract][Full Text] [Related]
10. Predictors of medication adherence in patients with type 2 diabetes mellitus.
Curkendall SM; Thomas N; Bell KF; Juneau PL; Weiss AJ
Curr Med Res Opin; 2013 Oct; 29(10):1275-86. PubMed ID: 23815104
[TBL] [Abstract][Full Text] [Related]
11. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
[TBL] [Abstract][Full Text] [Related]
12. Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes.
Banerji MA; Dunn JD
Am Health Drug Benefits; 2013 Sep; 6(7):382-92. PubMed ID: 24991370
[TBL] [Abstract][Full Text] [Related]
13. Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States.
Weiss T; Carr RD; Pal S; Yang L; Sawhney B; Boggs R; Rajpathak S; Iglay K
Patient Prefer Adherence; 2020; 14():2337-2345. PubMed ID: 33273810
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Characteristics Between Chinese Patients Taking Glucagon-like Peptide 1 Receptor Agonists and Insulin: A Cross-sectional Database Analysis.
Wang K; Chen Y; Strizek A; Boye K; Gu L; Liu Y; Qu S
Clin Ther; 2019 Oct; 41(10):2057-2065. PubMed ID: 31514971
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
Iglay K; Cartier SE; Rosen VM; Zarotsky V; Rajpathak SN; Radican L; Tunceli K
Curr Med Res Opin; 2015; 31(7):1283-96. PubMed ID: 26023805
[TBL] [Abstract][Full Text] [Related]
16. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol.
McGovern A; Tippu Z; Hinton W; Munro N; Whyte M; de Lusignan S
BMJ Open; 2016 Feb; 6(2):e010469. PubMed ID: 26928029
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes.
Hutchins V; Zhang B; Fleurence RL; Krishnarajah G; Graham J
Curr Med Res Opin; 2011 Jun; 27(6):1157-68. PubMed ID: 21466277
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
